Human IFNG/IFG/ IFI ORF/cDNA clone-Adenovirus plasmid (NM_000619.3)
Pre-made Human IFNG/IFG/ IFI adenoviral expression plasmid for IFNG adenovirus packaging, IFNG adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Go
to IFNG/IFG products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Plasmid Grade | Plasmid quantity |
---|---|---|---|
pGMAD000575 | Human IFNG Adenovirus plasmid | Research Grade | 10mg, 50mg, 100mg, 500mg, >1g |
GMP-like Grade | 10mg, 50mg, 100mg, 500mg, >1g | ||
High Quality (HQ) Grade | |||
Seed | 5ug |
Product Description
Catalog ID | pGMAD000575 |
Gene Name | IFNG |
Accession Number | NM_000619.3 |
Gene ID | 3458 |
Species | Human |
Product Type | Adenovirus plasmid (overexpression) |
Insert Length | 501 bp |
Gene Alias | IFG, IFI |
Fluorescent Reporter | EGFP |
Mammalian Cell Selection | |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
Sequence | ATGAAATATACAAGTTATATCTTGGCTTTTCAGCTCTGCATCGTTTTGGGTTCTCTTGGCTGTTACTGCCAGGACCCATATGTAAAAGAAGCAGAAAACCTTAAGAAATATTTTAATGCAGGTCATTCAGATGTAGCGGATAATGGAACTCTTTTCTTAGGCATTTTGAAGAATTGGAAAGAGGAGAGTGACAGAAAAATAATGCAGAGCCAAATTGTCTCCTTTTACTTCAAACTTTTTAAAAACTTTAAAGATGACCAGAGCATCCAAAAGAGTGTGGAGACCATCAAGGAAGACATGAATGTCAAGTTTTTCAATAGCAACAAAAAGAAACGAGATGACTTCGAAAAGCTGACTAATTATTCGGTAACTGACTTGAATGTCCAACGCAAAGCAATACATGAACTCATCCAAGTGATGGCTGAACTGTCGCCAGCAGCTAAAACAGGGAAGCGAAAAAGGAGTCAGATGCTGTTTCGAGGTCGAAGAGCATCCCAGTAA |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Biosimilar | GMP-Bios-ab-175 | Pre-Made Emapalumab biosimilar, Whole mAb, Anti-IFNG Antibody: Anti-IFG/IFI/IMD69 therapeutic antibody |
Biosimilar | GMP-Bios-ab-219 | Pre-Made Fontolizumab biosimilar, Whole mAb, Anti-IFNG Antibody: Anti-IFG/IFI/IMD69 therapeutic antibody |
Target Antibody | GM-Tg-g-T77664-Ab | Anti-IFNG/ IFG/ IFI functional antibody |
Target Antigen | GM-Tg-g-T77664-Ag | IFNG protein |
Cytokine | cks-Tg-g-GM-T77664 | interferon, gamma (IFNG) protein & antibody |
ORF Viral Vector | pGMAD000575 | Human IFNG Adenovirus plasmid |
ORF Viral Vector | pGMLP000461 | Human IFNG Lentivirus plasmid |
ORF Viral Vector | pGMAP000297 | Human IFNG Adenovirus plasmid |
ORF Viral Vector | vGMAD000575 | Human IFNG Adenovirus particle |
ORF Viral Vector | vGMLP000461 | Human IFNG Lentivirus particle |
ORF Viral Vector | vGMAP000297 | Human IFNG Adenovirus particle |
Target information
Target ID | GM-T77664 |
Target Name | IFNG |
Gene ID | 3458, 15978, 574282, 25712, 493965, 403801, 281237, 100034181 |
Gene Symbol and Synonyms | If2f,IFG,IFI,IFN-g,IFN-gamma,IFNG,IFNG2,IMD69 |
Uniprot Accession | P01579 |
Uniprot Entry Name | IFNG_HUMAN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | Therapeutics Target, Diagnostics Biomarker, Immuno-oncology Target, INN Index, Cytokine Target |
Disease | Breast Cancer |
Gene Ensembl | ENSG00000111537 |
Target Classification | Checkpoint-Immuno Oncology |
This gene encodes a soluble cytokine that is a member of the type II interferon class. The encoded protein is secreted by cells of both the innate and adaptive immune systems. The active protein is a homodimer that binds to the interferon gamma receptor which triggers a cellular response to viral and microbial infections. Mutations in this gene are associated with an increased susceptibility to viral, bacterial and parasitic infections and to several autoimmune diseases. [provided by RefSeq, Dec 2015]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.